Amy P Hsu Selected Research

GATA2 Transcription Factor

1/2022	ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome.
11/2020	Constructing and deconstructing GATA2-regulated cell fate programs to establish developmental trajectories.
2/2014	GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
2/2014	Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation.
4/2013	Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amy P Hsu Research Topics

Disease

13	Infections 10/2021 - 01/2008
12	GATA2 Deficiency 01/2022 - 09/2011
8	Neoplasms (Cancer) 01/2022 - 02/2006
6	Job Syndrome (Hyper-IgE Syndrome) 07/2013 - 10/2007
4	Coccidioidomycosis 01/2021 - 02/2011
4	Autoimmune Lymphoproliferative Syndrome 03/2014 - 02/2006
4	Opportunistic Infections (Opportunistic Infection) 02/2014 - 12/2010
3	Pulmonary Alveolar Proteinosis 10/2021 - 02/2010
3	Mycoses (Diseases, Fungus) 02/2019 - 12/2015
3	Pneumonia (Pneumonitis) 01/2019 - 10/2007
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2017 - 02/2014
2	Inflammation (Inflammations) 01/2022 - 02/2010
2	Disease Progression 01/2022 - 02/2017
2	Cytopenia 10/2021 - 02/2010
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 01/2020
2	Leukemia 11/2020 - 01/2017
2	Primary Immunodeficiency Diseases 01/2020 - 01/2019
2	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 01/2019 - 08/2016
2	Warts (Wart) 01/2019 - 04/2015
2	Chronic Granulomatous Disease 01/2019 - 04/2016
2	Lymphopenia (Lymphocytopenia) 01/2019 - 04/2013
2	autosomal recessive Candidiasis familial chronic mucocutaneous 10/2016 - 12/2015
2	Chronic Mucocutaneous Candidiasis 04/2016 - 06/2013
2	Heart Failure 01/2016 - 01/2015
2	Histoplasmosis 01/2016 - 06/2013
2	Lymphedema (Milroy Disease) 04/2015 - 02/2014
2	Lymphadenopathy 03/2014 - 04/2006
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2014 - 02/2014
2	Autoimmune Diseases (Autoimmune Disease) 12/2010 - 02/2006
2	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 07/2007 - 07/2002
1	Hematologic Diseases (Blood Diseases) 01/2022
1	Pulmonary Hypertension 10/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Bone Marrow Failure Disorders 01/2021
1	Brain Abscess (Abscess, Brain) 01/2020
1	Immediate Hypersensitivity 01/2019
1	Adenoviridae Infections (Adenovirus Infections) 01/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Allergic Rhinitis 01/2018
1	Aspergillosis 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Pruritus (Itching) 01/2018
1	Eosinophilic Esophagitis 01/2018
1	Invasive Pulmonary Aspergillosis 10/2016
1	Neutropenia 10/2016
1	Colitis 04/2016

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
5	GATA2 Transcription FactorIBA 01/2022 - 04/2013
5	AutoantibodiesIBA 01/2019 - 02/2010
4	Immunoglobulin E (IgE)IBA 01/2019 - 10/2007
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2018 - 11/2011
3	STAT1 Transcription FactorIBA 04/2016 - 06/2013
3	CytokinesIBA 01/2016 - 10/2007
3	InterferonsIBA 01/2016 - 08/2012
3	Biomarkers (Surrogate Marker)IBA 01/2016 - 03/2014
2	Busulfan (Busulfex)FDA Link 01/2022 - 01/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 01/2016
2	VaccinesIBA 01/2021 - 02/2019
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2016 - 01/2015
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2014 - 04/2006
2	ElementsIBA 05/2013 - 10/2012
2	DNA (Deoxyribonucleic Acid)IBA 10/2012 - 04/2011
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2012 - 02/2010
1	CohesinsIBA 01/2022
1	ChromatinIBA 01/2022
1	RNA Splicing FactorsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Pentostatin (Nipent)FDA LinkGeneric 01/2020
1	Specific Granule DeficiencyIBA 01/2020
1	AerosolsIBA 02/2019
1	Interferon alpha-2 (Roferon-A)FDA Link 01/2019
1	Superoxides (Superoxide)IBA 01/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019
1	Actins (F Actin)IBA 01/2019
1	5' Untranslated Regions (5' UTR)IBA 01/2018
1	perforin 2IBA 04/2017
1	Janus Kinase InhibitorsIBA 01/2017
1	Janus KinasesIBA 01/2017
1	Syk KinaseIBA 01/2017
1	ruxolitinibIBA 01/2017
1	Intracellular Signaling Peptides and ProteinsIBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Chemotactic FactorsIBA 10/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2016
1	NADP (NADPH)IBA 04/2016
1	Oxidoreductases (Dehydrogenase)IBA 04/2016
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 04/2016
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 04/2016
1	Dextrans (Dextran)FDA Link 04/2016
1	NF-kappa B (NF-kB)IBA 01/2016
1	Adenosine DeaminaseIBA 01/2016

Therapy/Procedure

6	Transplantation 01/2022 - 09/2011
6	Hematopoietic Stem Cell Transplantation 01/2022 - 09/2011
4	Stem Cell Transplantation 01/2022 - 02/2017
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2020 - 07/2002
2	Cell Transplantation 01/2021 - 01/2019
2	Therapeutics 01/2015 - 02/2008
1	Immunomodulation 01/2019
1	Drug Therapy (Chemotherapy) 10/2016